Discover this podcast and so much more

Podcasts are free to enjoy without a subscription. We also offer ebooks, audiobooks, and so much more for just $11.99/month.

010 The White Coat Effect is Real – The Role of Person in Plant Discussion - Daniel Torok

010 The White Coat Effect is Real – The Role of Person in Plant Discussion - Daniel Torok

FromCMC Live - Chemistry, Manufacturing & Controls


010 The White Coat Effect is Real – The Role of Person in Plant Discussion - Daniel Torok

FromCMC Live - Chemistry, Manufacturing & Controls

ratings:
Length:
40 minutes
Released:
Oct 2, 2020
Format:
Podcast episode

Description

What We Covered00:46 – Daniel Torok joins the show to share his experience as a process chemist and collaborating with CMOs in the pharmaceutical industry 07:54 – Daniel speaks to the importance of building trust in order to become an effective in-plant person 19:59 – Daniel details best practices he utilizes for site visits 24:15 – The information exchanged in a well-rounded site wrap up report 28:47 – Daniel shares some facts, myths and stories about CMOs 37:47 – Ed, Brian and Meranda thank Daniel for joining the show Tweetable Quotes“The White Coat Effect is real. Even in a good facility it’s absolutely real. When operators find out the client is coming they behave very differently and the level of detail is much more.” “Probably the most touching was I spent a lot of time on an API facility on the East Coast and, on the last day, their process chemist said, ‘I want to thank you. You’re the first person in plant who’s ever actually helped me.” “I warn them, ‘I’m gonna be there when you don’t really want me there.’” “Just because you walk out the door of the plant and you go to the airport and get on the plane, it [the process] shouldn’t be done or finished for us.” “I think one of the myths people have is that a CMO absolutely knows their equipment all the time and the process is going to be run the same every single time.”“It changes, it’s going to be fluid in this industry. Things happen. Things go wrong.” Relevant LinksDesign Space InPharmatics - LinkedInDesign Space InPharmatics - TwitterDaniel Torok on LinkedIn
Released:
Oct 2, 2020
Format:
Podcast episode

Titles in the series (27)

FDA CMC regulations and guidance simplified through examination, real life experiences and risk-based advice. This podcast hopes to educate sponsors and individuals on agency related regulatory CMC matters. We will focus on the critical CMC issues and build programs that enhance drug development. CMC topics will include Regulatory Starting Materials, API and Drug Product Process, Formulation Development, Supply Chains, Analytical Controls. Advocating and interpreting CMC Strategy, directing CMC Operations and Quality Assurance oversight in conjunction with developing CMC submission content that represents the best interests of emerging biotech. NOT INTENDED TO BE PRESCRIPTIVE ADVICE BUT RATHER INTERPRETATION THAT IS RIGHT FOR YOU. Since 2007 we have provided our partners with innovative strategies and exceptional advice intended to enhance program development, product approval, and marketing presence.